Sweden Inflammatory Bowel Disease Treatment Market Size & Outlook

The inflammatory bowel disease treatment market in Sweden is expected to reach a projected revenue of US$ 107.5 million by 2030. A compound annual growth rate of 5.4% is expected of Sweden inflammatory bowel disease treatment market from 2024 to 2030.

Revenue, 2023 (US$M)
$74.2
Forecast, 2030 (US$M)
$107.5
CAGR, 2024 - 2030
5.4%
Report Coverage
Sweden

Sweden inflammatory bowel disease treatment market, 2018-2030 (US$M)

Sweden

Related Markets

Sweden inflammatory bowel disease treatment market highlights

  • The Sweden inflammatory bowel disease treatment market generated a revenue of USD 74.2 million in 2023 and is expected to reach USD 107.5 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 5.4% from 2024 to 2030.
  • In terms of segment, crohn's disease was the largest revenue generating type in 2023.
  • Ulcerative Colitis is the most lucrative type segment registering the fastest growth during the forecast period.


Inflammatory bowel disease treatment market data book summary

Market revenue in 2023USD 74.2 million
Market revenue in 2030USD 107.5 million
Growth rate5.4% (CAGR from 2023 to 2030)
Largest segmentCrohn's disease
Fastest growing segmentUlcerative Colitis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCrohn's Disease, Ulcerative Colitis
Key market players worldwideAbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare


Other key industry trends

  • In terms of revenue, Sweden accounted for 0.4% of the global inflammatory bowel disease treatment market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany inflammatory bowel disease treatment market is projected to lead the regional market in terms of revenue in 2030.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 65.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Inflammatory Bowel Disease Treatment Market Scope

Inflammatory bowel disease treatment market segmentation & scope
Crohn's Disease
Ulcerative Colitis
Aminosalicylates
Corticosteroids
TNF Inhibitors
IL Inhibitors
Anti-integrin
JAK Inhibitors
Other Drug Class
Oral
Injectable
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Inflammatory Bowel Disease Treatment Market Companies

Name Profile # Employees HQ Website

Sweden inflammatory bowel disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.


Crohn's disease was the largest segment with a revenue share of 60.38% in 2023. Horizon Databook has segmented the Sweden inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.


Continuous developments by companies operating in the market are contributing to market growth. For instance, in July 2022, AbbVie announced that the European Commission approved RINVOQ for the treatment of severe to moderate ulcerative colitis. The approval is based on phase III study results, and it is RINVOQ’s fifth therapeutic indication in the European Union.

Furthermore, in November 2021, Galapagos NV announced that the European Commission granted marketing authorization to nilotinib 200 mg tablets for the treatment of moderate to severe ulcerative colitis.

In addition, the growing demand for biosimilars in the country is facilitating its market growth. For instance, in October 2018, Amgen announced that AMGEVITA, a biosimilar approved by European Commission, has been authorized for the management of inflammatory diseases, including psoriatic arthritis and moderate-tosevere Crohn's disease & ulcerative colitis.

Reasons to subscribe to Sweden inflammatory bowel disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden inflammatory bowel disease treatment market databook

  • Our clientele includes a mix of inflammatory bowel disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden inflammatory bowel disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Sweden inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden inflammatory bowel disease treatment market size, by type, 2018-2030 (US$M)

Sweden Inflammatory Bowel Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)

Sweden inflammatory bowel disease treatment market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more